NM_001024845.3:c.319+71C>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001024845.3(SLC6A9):​c.319+71C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000142 in 1,404,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

SLC6A9
NM_001024845.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.502

Publications

0 publications found
Variant links:
Genes affected
SLC6A9 (HGNC:11056): (solute carrier family 6 member 9) The amino acid glycine acts as an inhibitory neurotransmitter in the central nervous system. The protein encoded by this gene is one of two transporters that stop glycine signaling by removing it from the synaptic cleft. [provided by RefSeq, Jun 2016]
SLC6A9 Gene-Disease associations (from GenCC):
  • atypical glycine encephalopathy
    Inheritance: Unknown, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • infantile glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001024845.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A9
NM_001024845.3
MANE Select
c.319+71C>A
intron
N/ANP_001020016.1P48067-2
SLC6A9
NM_201649.4
c.538+71C>A
intron
N/ANP_964012.2P48067-1
SLC6A9
NM_006934.4
c.376+71C>A
intron
N/ANP_008865.2P48067-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A9
ENST00000372310.8
TSL:5 MANE Select
c.319+71C>A
intron
N/AENSP00000361384.4P48067-2
SLC6A9
ENST00000360584.6
TSL:1
c.538+71C>A
intron
N/AENSP00000353791.2P48067-1
SLC6A9
ENST00000357730.6
TSL:1
c.376+71C>A
intron
N/AENSP00000350362.2P48067-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000142
AC:
2
AN:
1404090
Hom.:
0
AF XY:
0.00000144
AC XY:
1
AN XY:
696340
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31966
American (AMR)
AF:
0.00
AC:
0
AN:
41024
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23434
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79290
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51622
Middle Eastern (MID)
AF:
0.000220
AC:
1
AN:
4552
European-Non Finnish (NFE)
AF:
9.30e-7
AC:
1
AN:
1075114
Other (OTH)
AF:
0.00
AC:
0
AN:
57902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.2
DANN
Benign
0.51
PhyloP100
-0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16831541; hg19: chr1-44475566; API